NEW BRUNSWICK, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") , today announced that, on February 1, 2010, Sascha P. Fedyszyn resigned from his position as the Company's Vice President of Corporate Development and Secretary to pursue other interests. The Company's current President and Chief Executive Officer, Jack Van Hulst, will assume Mr. Fedyszyn's responsibilities and serve as the Company's Secretary.
About Senesco Technologies, Inc.
Senesco Technologies, Inc. is a U.S. biotechnology company, headquartered in New Brunswick, NJ. Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain inflammatory and ischemic diseases. Senesco takes its name from the scientific term for the aging of plant cells: senescence. Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress. The Company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products.
CONTACT: Company Contact: Jack Van Hulst, President and Chief Executive
Officer of Senesco Technologies, Inc., +1-732-296-8400,
jvanhulst@senesco.com; or Investor Relations Contact: Brian Ritchie of FD,
+1-212-850-5600, brian.ritchie@fd.com
Web site: http://www.senesco.com/
